1. LawStack
  2. Title 21 - Food and Drugs
  3. Chapter I - FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES
  4. Subchapter E - ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS
  5. Part 556 - TOLERANCES FOR RESIDUES OF NEW ANIMAL DRUGS IN FOOD
  6. Subpart B - Specific Tolerances for Residues of Approved and Conditionally Approved New Animal Drugs
  7. 21 CFR § 556.226
21 CFR § 556.226
Enrofloxacin
June 25, 2020
CFR

(a) Acceptable daily intake (ADI). The ADI for total residue of enrofloxacin is 3 µg/kg of body weight per day.

(b) Tolerances. The tolerances for enrofloxacin are:

(1) Cattle. Liver (target tissue): 0.1 ppm desethylene ciprofloxacin (marker residue).

(2) Swine. Liver (target tissue): 0.5 ppm enrofloxacin (marker residue).

(c) Related conditions of use. See §522.812 of this chapter.

Previous
§ 556.224 Efrotomycin
Next
§ 556.227 Eprinomectin

Tried the LawStack mobile app?

Join thousands and try LawStack mobile for FREE today.

  • Carry the law offline, wherever you go.
  • Download CFR, USC, rules, and state law to your mobile device.

Designed and built by Tekk Innovations LLC, the makers of the LawStack iPhone app or Android app.

© 2020 Tekk Innovations LLC